NIMBLE, NCT05070858 / 2020-003272-41: A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis |
|
|
| Recruiting | 3 | 235 | Europe, Canada, Japan, US, RoW | Pozelimab + Cemdisiran, Cemdisiran, ALN-CC5, Placebo, Pozelimab, REGN3918 | Regeneron Pharmaceuticals | Generalized Myasthenia Gravis | 05/25 | 03/28 | | |
| Completed | N/A | 40 | RoW | Magstim rTMS | Peking Union Medical College Hospital | Primary Progressive Aphasia, Repetitive Transcranical Magnetic Stimulation | 07/22 | 08/22 | | |
| Recruiting | N/A | 1500 | RoW | | Huashan Hospital, China Alliance for Rare Diseases, National Center for Neurological Disorders (China), China myasthenia gravis collaborating group (CMGCG) | Myasthenia Gravis | 02/34 | 01/35 | | |
NCT06006832: A Prospective Cohort Study of Myasthenia Gravis in China |
|
|
| Recruiting | N/A | 202 | RoW | Steroid Drug, Withdraw all immunosuppresants | Peking Union Medical College Hospital | Myasthenia Gravis | 09/26 | 09/26 | | |
